Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives

References

• Simelela PN. WHO global strategy to eliminate cervical cancer as a public health problem: an opportunity to make it a disease of the past. Int J Gynecol Obstet. 2021;152(1):1–10. doi:10.1002/ijgo.13484.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi:10.3322/CAAC.21660.
   PubMed Web of Science ®Google Scholar
• Cunningham MS, Davison C, Aronson KJ. HPV vaccine acceptability in Africa: a systematic review. Prev Med (Baltim). 2014;69:274–79. doi:10.1016/J.YPMED.2014.08.035.
   PubMed Web of Science ®Google Scholar
• CDC. How many cancers are linked with HPV each year? CDC; Published 2020 [accessed 2021 Aug 17]. https://www.cdc.gov/cancer/hpv/statistics/cases.htm.
   Google Scholar
• Kane MA. Preventing cancer with vaccines: progress in the global control of cancer. Cancer Prev Res (Phila). 2012;5(1):24–29. doi:10.1158/1940-6207.CAPR-11-0533.
   PubMed Web of Science ®Google Scholar
• WHO. World Health Assembly adopts global strategy to accelerate cervical cancer elimination. Published 2020 [accessed 2020 Dec 3]. https://www.who.int/news/item/19-08-2020-world-health-assembly-adopts-global-strategy-to-accelerate-cervical-cancer-elimination.
   Google Scholar
• Gajjar SR, Bernard J, Cantave J, Ventura NC, Cornely JR, Damuse R, Gassant Heurtelou PY, Luginbuhl AJ, Raymondville M, DeGennaro V. Implementing radiation therapy in Haiti: current status and future directions. Int J Radiat Oncol Biol Phys. 2018;102(3):478–82. doi:10.1016/j.ijrobp.2018.06.025.
   PubMedGoogle Scholar
• DeGennaro V, Gibbs M, Wilson C, Louis N, Kanyandekwe D, Petterson C. Women’s cancer screening in Haiti: increasing access by bringing services to the workplace. J Glob Oncol. 2018;4(Supplement 2):209s–209s. doi:10.1200/jgo.18.84300.
   Google Scholar
• Moise RK, Jonas E, Campa EM, Clisbee M, Lopes G, Kobetz E. Bayo Lapawol (Let their voices be heard): Haitian women’s barriers to and facilitators of cervical cancer prevention and control. Heal Educ Behav. 2021;48:109019812199038. Published online February 23, 2021. doi:10.1177/1090198121990381.
   Google Scholar
• Burchett HED, Mounier-Jack S, Griffiths UK, Mills AJ. National decision-making on adopting new vaccines: a systematic review. Health Policy Plan. 2012;27(suppl_2):ii62–76. doi:10.1093/HEAPOL/CZR049.
   PubMedGoogle Scholar
• Burchett HED, Mounier-Jack S, Griffiths UK, Biellik R, Ongolo-Zogo P, Chavez E, Sarma H, Uddin J, Konate M, Kitaw Y, et al. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. Health Policy Plan. 2012;27(SUPPL.2):ii5–16. doi:10.1093/HEAPOL/CZS035.
   PubMedGoogle Scholar
• Gordon WS, Jones A, Wecker J. Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges. Health Policy Plan. 2012;27(SUPPL.2):ii17–26. doi:10.1093/HEAPOL/CZS040.
   PubMedGoogle Scholar
• Romore I, Njau RJA, Semali I, Mwisongo A, Ba Nguz A, Mshinda H, Tanner M, Abdulla S. Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania. Malar J. 2016;15(1):143. doi:10.1186/S12936-016-1197-6.
   PubMedGoogle Scholar
• Abdullahi LH, Hussey GD, Wiysonge CS, Kagina BM. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: stakeholders’ perspectives. South Afr Med J. 2020;110(6):525–31. doi:10.7196/SAMJ.2020.v110i6.14332.
   PubMed Web of Science ®Google Scholar
• Deignan C, Swartz A, Cooper S, Colvin CJ. Stakeholders’ understandings of Human Papillomavirus (HPV) vaccination in Sub-Saharan Africa: a rapid qualitative systematic review. Vaccines. 2021;9(5):496. doi:10.3390/VACCINES9050496.
   Web of Science ®Google Scholar
• Steffen CA, Henaff L, Durupt A, Omeiri NE, Ndiaye S, Batmunkh N, Liyanage JBL, Hasan Q, Mosina L, Jones I, et al. Evidence-informed vaccination decision-making in countries: progress, challenges and opportunities. Vaccine. 2021;39:2146–52. Published online 2021. doi:10.1016/j.vaccine.2021.02.055.
   PubMed Web of Science ®Google Scholar
• Shinkafi-Bagudu Z. Global partnerships for HPV vaccine must look beyond national income. JCO Global Oncol. 2020;(6):1746–48. doi:10.1200/GO.20.00504.
   PubMedGoogle Scholar
• Wigle J, Coast E, Watson-Jones D. Human Papillomavirus (HPV) vaccine implementation in Low and Middle-Income Countries (LMICs): health system experiences and prospects. Vaccine. 2013;31(37):3811–17. doi:10.1016/j.vaccine.2013.06.016.
   PubMed Web of Science ®Google Scholar
• Amponsah-Dacosta E, Blose N, Nkwinika VV, Chepkurui V. Human papillomavirus vaccination in South Africa: programmatic challenges and opportunities for integration with other adolescent health services? Front Public Health. 2022;10:59. doi:10.3389/FPUBH.2022.799984.
   Web of Science ®Google Scholar
• IVAC. View-Hub. Published 2022 [accessed 2022 Aug 28]. https://view-hub.org/.
   Google Scholar
• WHO. HPV vaccine introduction dashboard. Published 2022 [accessed 2022 Aug 29]. https://app.powerbi.com/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktYWFlYTdkOGU2NDcwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9.
   Google Scholar
• MacQueen KM, McLellan E, Kay K, Milstein B. Codebook development for team-based qualitative analysis. Cam J. 1998;10(2):31–36. doi:10.1177/1525822X980100020301.
   Google Scholar
• DeRoeck D, Deen J, Clemens JD. Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries. Vaccine. 2003;22(1):121–29. doi:10.1016/S0264-410X(03)00533-4.
   PubMed Web of Science ®Google Scholar
• Muangchana C, Thamapornpilas P, Karnkawinpong O. Immunization policy development in Thailand: the role of the advisory committee on immunization practice. Vaccine. 2010;28(SUPPL. 1):A104–09. doi:10.1016/J.VACCINE.2010.02.043.
   PubMedGoogle Scholar
• Hadisoemarto PF, Reich MR, Castro MC. Introduction of pentavalent vaccine in Indonesia: a policy analysis. Health Policy Plan. 2016;31(8):1079–88. doi:10.1093/HEAPOL/CZW038.
   PubMed Web of Science ®Google Scholar
• Dawa J, Chaves SS, Ba Nguz A, Kalani R, Anyango E, Mutie D, Muthoka P, Tabu C, Maritim M, Amukoye E, et al. Developing a seasonal influenza vaccine recommendation in Kenya: process and challenges faced by the National Immunization Technical Advisory Group (NITAG). Vaccine. 2019;37(3):464–72. doi:10.1016/J.VACCINE.2018.11.062.
   PubMed Web of Science ®Google Scholar
• Otieno NA, Malik FA, Nganga SW, Wairimu WN, Ouma DO, Bigogo GM, Chaves SS, Verani JR, Widdowson M-A, Wilson AD, et al. Decision-making process for introduction of maternal vaccines in Kenya, 2017–2018. Implement Sci. 2021;16(1):1–15. doi:10.1186/S13012-021-01101-7/TABLES/6.
   PubMed Web of Science ®Google Scholar
• Ba-Nguz A, Adjagba A, Wisnu Hendrarto T, Sewankambo NK, Nalwadda C, Kisakye A. The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of inactivated polio vaccine: experience of the Indonesia and Uganda NITAGs. J Infect Dis. 2017;216(suppl_1):S109–13. doi:10.1093/INFDIS/JIW601.
   PubMedGoogle Scholar
• Delany-Moretlwe S, Chersich M, Harvey S, Stangl A, Baron D, Columbini M, Scorgie F, Naicker N, Kapiga S. Empowerment clubs did not increase PrEP continuation among adolescent girls and young women in South Africa and Tanzania-results from the EMPOWER randomised trial. J Int AIDS Soc. 2018;21. doi:10.1002/jia2.25148.
   Web of Science ®Google Scholar
• Amponsah-Dacosta E, Kagina BM, Olivier J. Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review. Health Policy Plan. 2020;35(6):701–17. doi:10.1093/HEAPOL/CZAA017.
   PubMed Web of Science ®Google Scholar
• Riviere C, Bell T, Cadot Y, Perodin C, Charles B, Bertil C, Cheung J, Bane S, Cheung HC, Pape JW, et al. Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti. PLoS One. 2021;16(6):e0252310. doi:10.1371/JOURNAL.PONE.0252310.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in Sub-Saharan Africa. Vaccine. 2013;31(Suppl 5):F47–52. doi:10.1016/j.vaccine.2012.06.066.
   PubMedGoogle Scholar
• Morgan C, Giattas MR, Holroyd T, Pfitzer A, Engel D, Sidibe A, Holloway M, Bloem P, Fields R, Shimp L, et al. Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence. Vaccine. 2022;40:A94–99. Published online 2022. doi:10.1016/J.VACCINE.2021.12.066.
   PubMed Web of Science ®Google Scholar
• Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90(8):623. doi:10.2471/BLT.11.097253.
   PubMed Web of Science ®Google Scholar
• Dochez C, Burnett RJ, Mbassi SM, Were F, Musyoki A, Trovoada D, Mphahlele MJ. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction. Papillomavirus Res. 2017;4:66–71. doi:10.1016/J.PVR.2017.08.003.
   PubMed Web of Science ®Google Scholar
• Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju R, Shayo B, Giattas MR, Loharikar A, Lyimo D. National introduction of human papillomavirus (HPV) vaccine in Tanzania: programmatic decision-making and implementation. Vaccine. 2022;40:A2–9. Published online May 4, 2021. doi:10.1016/J.VACCINE.2021.04.025.
   PubMed Web of Science ®Google Scholar